Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Improved insulin sensitivity after gastric bypass correlates with decreased total body fat, but not with changes in free fatty acids.

Mor A, Tabone L, Omotosho P, Torquati A.

Surg Endosc. 2014 May;28(5):1489-1493. doi: 10.1007/s00464-013-3338-0. Epub 2013 Dec 7.

2.

Effect of laparoscopic Roux-en-Y gastric bypass on body composition and insulin resistance in Chinese patients with type 2 diabetes mellitus.

Li W, Zhu L, Mo Z, Yang X, Wang G, Li P, Tan J, Ye F, Strain J, Im I, Zhu S.

Obes Surg. 2014 Apr;24(4):578-83. doi: 10.1007/s11695-013-1116-7.

PMID:
24214201
3.

Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).

Yi B, Jiang J, Zhu L, Li P, Im I, Zhu S.

Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1061-8. doi: 10.1016/j.soard.2014.12.029. Epub 2015 Jan 5.

PMID:
25843397
4.
5.
7.

GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.

Ann Surg. 2013 May;257(5):894-9. doi: 10.1097/SLA.0b013e31826b8603.

PMID:
23579541
8.

Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.

Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G.

Ann Surg. 2013 Mar;257(3):462-8. doi: 10.1097/SLA.0b013e318269cf5c.

PMID:
23388352
9.

Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.

Bush NC, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD.

J Clin Endocrinol Metab. 2012 Nov;97(11):4130-8. doi: 10.1210/jc.2012-2285. Epub 2012 Aug 29.

10.

Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.

Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC 3rd, Moody FG, Lux TR, Taegtmeyer H.

Am J Med. 2009 May;122(5):435-42. doi: 10.1016/j.amjmed.2008.10.035.

11.

Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test.

Soriguer F, García-Serrano S, García-Almeida JM, Garrido-Sánchez L, García-Arnés J, Tinahones FJ, Cardona I, Rivas-Marín J, Gallego-Perales JL, García-Fuentes E.

Obesity (Silver Spring). 2009 Jan;17(1):10-5. doi: 10.1038/oby.2008.475. Epub 2008 Oct 23.

12.

Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.

Luo P, Yu H, Zhao X, Bao Y, Hong CS, Zhang P, Tu Y, Yin P, Gao P, Wei L, Zhuang Z, Jia W, Xu G.

J Proteome Res. 2016 Apr 1;15(4):1288-99. doi: 10.1021/acs.jproteome.6b00022. Epub 2016 Feb 25.

PMID:
26889720
13.

Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.

Dogan K, Betzel B, Homan J, Aarts EO, Ploeger N, de Boer H, Aufenacker TJ, van Laarhoven CJ, Janssen IM, Berends FJ.

Obes Surg. 2014 Nov;24(11):1835-42. doi: 10.1007/s11695-014-1310-2.

PMID:
25027982
14.

Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.

van de Laar AW, de Brauw LM, Meesters EW.

Surg Obes Relat Dis. 2016 Feb;12(2):274-82. doi: 10.1016/j.soard.2015.07.005. Epub 2015 Jul 9.

PMID:
26476492
15.

Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.

Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C.

Surg Obes Relat Dis. 2011 Sep-Oct;7(5):561-8. doi: 10.1016/j.soard.2011.01.044. Epub 2011 Mar 22.

PMID:
21429816
16.

Using the hyperinsulinemic euglycemic clamp to assess insulin sensitivity at 3 months following Roux-en-Y gastric bypass surgery in type 2 diabetes patients with BMI <35 kg/m2 in China.

Zhao L, Zhu L, Su Z, Liu Y, Li P, Yang X, Li W, Tan L, Sun X, Zhu S.

Int J Surg. 2017 Feb;38:90-94. doi: 10.1016/j.ijsu.2016.12.120. Epub 2016 Dec 30.

PMID:
28043929
17.

Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.

Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR.

Diabetes Obes Metab. 2014 Dec;16(12):1230-8. doi: 10.1111/dom.12376. Epub 2014 Sep 14.

18.

Predictors of metabolic syndrome persistence 1 year after laparoscopic Roux-en-Y gastric bypass.

Martini F, Anty R, Schneck AS, Casanova V, Iannelli A, Gugenheim J.

Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1054-60. doi: 10.1016/j.soard.2015.02.019. Epub 2015 Feb 25.

PMID:
25868838
19.

Effectiveness of laparoscopic Roux-en-Y gastric bypass on obese class I type 2 diabetes mellitus patients.

Xu L, Yin J, Mikami DJ, Portenier DD, Zhou X, Mao Z.

Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1220-6. doi: 10.1016/j.soard.2015.02.013. Epub 2015 Feb 19.

PMID:
26054489
20.

Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels.

Raffaelli M, Iaconelli A, Nanni G, Guidone C, Callari C, Fernandez Real JM, Bellantone R, Mingrone G.

Br J Surg. 2015 May;102(6):682-90. doi: 10.1002/bjs.9780. Epub 2015 Mar 23.

PMID:
25808987

Supplemental Content

Support Center